| Date Filed | Type | Description |
| 02/23/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/23/2020 |
4
| Alpha Holdings, Inc. (Director) has filed a Form 4 on ONCOSEC MEDICAL Inc|
Txns:
| Sold 80,000 shares
@ $4.9234, valued at
$393.9k
|
|
| 11/20/2020 |
4
| Alpha Holdings, Inc. (Director) has filed a Form 4 on ONCOSEC MEDICAL Inc|
Txns:
| Sold 50,000 shares
@ $5.1046, valued at
$255.2k
|
|
| 11/19/2020 |
4
| Alpha Holdings, Inc. (Director) has filed a Form 4 on ONCOSEC MEDICAL Inc|
Txns:
| Sold 40,000 shares
@ $5.2416, valued at
$209.7k
Sold 10,999 shares
@ $5.2416, valued at
$57.7k
|
|
| 11/18/2020 |
SC 13D/A
| Alpha Holdings, Inc. reports a 6.8% stake in ONCOSEC MEDICAL INCORPORATED |
| 11/18/2020 |
4
| Alpha Holdings, Inc. (Director) has filed a Form 4 on ONCOSEC MEDICAL Inc|
Txns:
| Sold 40,000 shares
@ $5.4082, valued at
$216.3k
Sold 40,000 shares
@ $5.1686, valued at
$206.7k
|
|
| 02/03/2020 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
| 02/03/2020 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
| 02/03/2020 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
| 01/29/2020 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
| 01/27/2020 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
| 01/27/2020 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
| 01/27/2020 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
| 01/27/2020 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
| 01/21/2020 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
| 01/17/2020 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
| 01/17/2020 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party: |
| 01/17/2020 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
| 01/17/2020 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
| 01/17/2020 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
| 01/15/2020 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party: |
| 01/15/2020 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
| 01/15/2020 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
| 01/15/2020 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
| 01/15/2020 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
| 01/14/2020 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
| 01/14/2020 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
| 01/14/2020 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party: |
| 01/14/2020 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
| 01/14/2020 |
SC 13D/A
| Alpha Holdings, Inc. reports a 15.1% stake in ONCOSEC MEDICAL INCORPORATED |
| 01/08/2020 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
| 01/08/2020 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
| 01/07/2020 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
|